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Background: Chinese primary care settings have a heavy patient load, shortage of physicians, limited medical
resources and low medical literacy, making it difficult to screen for developmental disorders in infants. The Infant
Neurological International Battery (INFANIB) for the assessment of neuromotor developmental disorders in infants
aged 0 ~ 18 months is widely applied in community health service centers because of its simplicity, time-saving
advantages and short learning curve. We aimed to develop and assess a Chinese version of the INFANIB.
Methods: A Chinese version of the INFANIB was developed. Fifty-five preterm and 49 full-term infants with high
risk of neurodevelopmental delays were assessed using the Chinese version of the INFANIB at 3, 7 and 10 months
after birth. The Peabody Developmental Motor Scale (PDMS) was simultaneously used to assess the children with
abnormalities and diagnose cerebral palsy. The sensitivity, specificity, positive predictive value and negative
predictive value of the scale were calculated.
Results: At birth, a higher proportion of full-term infants had asphyxia (p< 0.001), brain damage (p= 0.003) and
hyperbilirubinemia (p= 0.022). The interclass correlation coefficient and intraclass correlation coefficient values for
the INFANIB at 3, 7 and 10 months were >0.8, indicating excellent reliability with regard to inter- and intraobserver
differences. The specificity, sensitivity, positive predictive value and negative predictive value were high for both
high-risk premature infants and full-term infants at the age of 10 months. For premature infants at the age of
7 months or below, INFANIB had low validity for detecting abnormalities.
Conclusions: The Chinese version of the INFANIB can be useful for screening infants with high-risk for neuromotor
abnormality in Chinese primary care settings.
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The survival of high-risk infants with premature deliv-
ery, low birth weight, intrauterine growth retardation,
birth asphyxia, intraventricular hemorrhage or chronic
lung diseases has increased significantly through the de-
velopment of medical technology for perinatal care. In
2010, the World Health Organization reported that the
incidence of premature delivery is 10%, and 54% of pre-
mature infants are born in Asia [1]. Premature infants* Correspondence: zhao_54@163.com
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reproduction in any medium, provided the orcomprise a special group of high-risk infants. Their
motor development is different from that of healthy full-
term infants and their incidence of motor disorders is
higher than their incidence of recognition and behavioral
disorders [2]. Evidence is growing that the first year of
an infant’s life is a critical period for brain develop-
ment due to brain plasticity [3-6]. Motor development
during the first year of life is rapid and extensive and
is influenced by biological, environmental, and social
factors. Interventions during the first year of life can
significantly improve the outcome of neuromotor
abnormalities.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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incidence of neuromotor abnormalities and cognitive
and behavioral disorders in infants is increasing. In
China, the community healthcare setting plays a critical
role in early identification of neuromotor abnormalities
in infants. However, knowledge of medical professionals
about neuromotor abnormalities in high-risk infants
remains insufficient. Thus, it is imperative to develop a
scale that is simple to apply, requires only a short time
for assessment and provides favorable reliability and val-
idity for identifying neuromotor abnormalities in infants
in Chinese primary care settings.
Currently in China, several scales are applied in lim-
ited general hospitals for measuring infant neuromotor
development, including the Bayley Scales of Infant De-
velopment (BSID-II) [7], the Gesell development sche-
dules [8], and the Peabody Developmental Motor Scales,
Second Edition, (PDMS-2) [9]. The Alberta Infant Motor
Scale (AIMS) [10] has been investigated but is not yet
widely applied in Chinese clinical settings. Other scales
such as the Test of Infant Motor Performance (TIMP)
[11] and Toddler and Infant Motor Evaluation (TIME)
[12] have not yet been introduced in China. Reports of
the above mentioned instruments suggest that they are
time consuming and require specialized training, which
makes them impractical for routine use in China where
most communities have an abundance of patients, a
shortage of physicians, limited medical resources and
low medical literacy. Another investigative tool has been
introduced, however, that appears to have wide applica-
tion in community health service centers because of its
simplicity and time-saving advantages, and its short
learning curve for physicians, nurses and physical thera-
pists. Ellison and colleagues developed the Infant Neuro-
logical International Battery (INFANIB) for the
assessment of neuromotor developmental disorders in
infants aged 0 ~ 18 months [13]. The original INFANIB
was a 20-item battery with five factors: Spasticity, Ves-
tibular Function, Head and Trunk, French Angles and
Legs. The INFANIB was validated in Iran and its sensi-
tivity was 90%, specificity 83%, positive predictive value
(PPV) 79% and negative predictive value (NPV) 93%
[14]. The intraclass correlation coefficient (ICC) was
0.90. Studies have confirmed that the INFANIB is easy
to apply and time-saving. North American and Iranian
studies have shown that this scale has favorable reliabil-
ity and validity in the prediction of gross motor develop-
ment, and its assessment procedures can be mastered by
medical personnel of different professions, including
clinicians and nurses [14,15].
Differences in attaining gross motor milestones have
been noted among different ethnic groups; in one study,
Indian Black Caribbean, and Black African children were
found less likely to be delayed (in adjusted models),while increased likelihood of delays was seen among
Pakistani and Bangladeshi infants, after considering
socio-economic factors [16]. Racial and ethnic variations
were also noted among American children; black infants
were advanced in motor development in their first two
years and as they became school age, especially boys,
they consistently performed better than white and His-
panic children in activities such as running and vertical
jumps, while white and Hispanic children had less con-
sistent performance overall in motor development skills
[17]. Considering ethnic variations, we feel that it is ap-
propriate and necessary for the reliability and validity of
a Chinese version of the INFANIB to be confirmed in a
Chinese population. The present study was carried out
to develop a Chinese version of the INFANIB to assess
its reliability and validity and to explore its feasibility for
screening neuromotor developmental disorders in Chin-
ese primary care settings.Methods
Subjects
A total of 118 infants evaluated at an out-patient clinic
and hospitalized for high-risk neurodevelopmental
delays from January 2008 to December 2010 were ran-
domly selected for this study. All infants had no gen-
etic abnormalities and had been hospitalized in the
neonatal intensive care unit (NICU). These infants
were Han Chinese from the Chongqing region of
China. The ratio of suburban to urban infants was 4:1.
The age at first hospital visit was 1–3 months (cor-
rected age for premature infants). Infants who did not
complete follow-up were excluded from the study. One
hundred four infants were assessed for neuromotor de-
velopment at 3, 7 and 10 months and then followed
up until they reached age one year. After one year
(12–24 months), the PDMS-2 was administered by
professional evaluators to assess motor development
outcomes and cerebral palsy was diagnosed simultan-
eously by pediatricians based on severe abnormal
motor development (See details below.). If diagnosis of
CP is not confirmed, follow up is needed, including
repeat evaluation by PDMS-2. For the purpose of ana-
lyzing predictive validity, the infants were divided into
premature infants (n = 55) and full-term high-risk
infants (n = 49).Ethical considerations
In compliance with the Helsinki Declaration, the study
protocol was reviewed and approved by the Institutional
Review Board of the 2nd Affiliated Hospital of the Third
Military Medical University, China (No. 2007082) on
December 6, 2007. Signed informed consent was pro-
vided by the parents or legal guardians of all subjects.
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For the purposes of this study, developmental and clin-
ical terms were defined as follows:
Asphyxia was defined as infants with fetal acidosis
(pH <7.0), a 5-min Apgar score of 0–3. HIE (e.g.,
altered tone, depressed level of consciousness, seizures)
and other multiorgan system signs (e.g., altered
consciousness, muscle tone, posture, tendon reflexes/
clonust, myclonus present/absent, pupils, seizures, etc.).
Brain damage was defined as presence of HIE of
full-term infants and periventricular leukomalacia
(PVL) or preterm infants.
Hypoxic ischemic encephalopathy (HIE) is an important
cause of permanent damage to central nervous system
cells it may result in neonatal death or manifest as
cerebral palsy or mental deficiency. HIE was diagnosed
based on: a)profound metabolic or mixed acidemia
(pH <7.0) in an umbilical arterial blood sample.
b)an Apgar score of 0 to 3 for > 5 min. c) neurological
manifestation such as seizure, coma or hypotonia and
d) evidence of multiorgan dysfunction.
Intracranial hemorrhage may results from trauma or
asphyxia and rarely from a primary hemorrhagic
disturbance or congenital vascular anomaly. It was
defined based on history and clinical manifestations
(e.g., large fetal head in proportion to pelvic outlet,
prolonged labor, breech presentation, mechanical
assistance with delivery), transfontanel cranial
ultrasonography or CT results and knowledge of the
birth weight-specific risks of the type of hemorrhage.
Periventricular leukomalacia (PVL) was defined as
presence of focal necrotic lesions in the periventricular
white matter and/or more diffuse white matter damage
as indicated by results of cranial ultrasound and/or
other imaging modalities, especially when performed
on infants with intraventricular hemorrhage and/or
ventriculomegaly who are at high risk for PVL.
Pregnancy induced hypertension (maternal
hypertension) was defined as development of new
arterial hypertension in the pregnant woman after
20-weeks gestation without presence of protein
in the urine.
Infant neurological international battery
(INFANIB)-Chinese version
Translation and cultural adaptation
The procedures and criteria for assessment of the 20-
item INFANIB scale were translated into Chinese by
two doctors specializing in developmental pediatrics.
The initial version was then translated back into Eng-
lish by an English teacher who was not knowledgeable
about developmental pediatrics. The English version
was sent to a professor in the Department of PhysicalTherapy of Hung Kuang University who had substan-
tial experience in assessment using the INFANIB. The
professor revised and approved this Chinese version of
the INFANIB.Assessment
All infants were assessed with the Chinese version of the
INFANIB at months 3, 7 and 10 (corrected age for pre-
mature infants) by three medical staff members: a child-
care physician (rater A), a nurse with 5 years experience
in a neonatal ICU (rater B) and a physical therapist
(rater C). The cut points for INFANIB scores were
established as described previously [15]. For infants
<4 months old, abnormal ≤ 48, transient = 49–65, and
normal ≥ 66. For infants 4 to 8 months old, the cut
points were abnormal ≤ 54, transient = 55–71, and nor-
mal ≥ 72. For infants ≥8 months old, the cut points were
abnormal ≤ 68, transient = 69–82, and normal ≥ 83.Determination of gross motor development outcomes
by PDMS
At age one year, all infants underwent assessment for
motor development outcome by professional evaluators
who used the Peabody Developmental Motor Scales,
Second Edition (PDMS-2) for quantitative and qualita-
tive evaluation of motor development [18]. The PDMS
includes two independent scales to evaluate gross and
fine motor development in children: the gross motor
evaluation scale comprises 151 items to detect reflexes,
equilibrium, acquirement and release, stationary and
locomotion; the fine motor evaluation scales comprise
98 items to evaluate grasping, use of hands, visual-
motor integration and object manipulation [9,18]. Reli-
ability and validity of the PDMS-2 Chinese version was
reported by Yang et al. in 2010 (in Chinese)[19]. In
addition, experts in developmental pediatrics evaluated
the infants for cerebral palsy (CP), basing their diag-
nosis on severe abnormal motor development out-
comes and the international criteria for CP [20]. A
Gross Motor Quotient (GMQ) score in the PDMS-2
of ≤79 was defined as motor development retardation
[9]. Infants without CP and a normal PDMS-2 score
were considered to have normal motor development.
Parents accompanied their infants to promote optimal
performance during assessment with the PDMS-2.
Infants with normal neuromotor development at age
one year were subsequently (12–24 months) followed
up in the clinic using PDMS-2 evaluation and those
with abnormalities received rehabilitation training in
our hospital. Infants with transient stage were fol-
lowed up once monthly. During the follow-up period,
a physical therapist provided guidance and advice for
rehabilitation training.
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Reliability
The interclass correlation coefficient (ICC-inter) and
the intraclass correlation coefficient (ICC-intra) were
used to assess reliability. Assessment of infants was
repeated 3–5 days after the first assessment. The rela-
tionship of scores between rater B and C was used to
determine the test-retest reliability. The relationship of
scores among the three raters was used to measure
intergroup reliability.
Validity
The PDMS-2 was used as the gold standard for measur-
ing motor development. The presence of CP or GMQ
≤79 on the PDMS-2 was considered to be a motor de-
velopment disorder. “Abnormal and transient” on INFA-
NIB assessment was defined as positive for neuromotor
developmental disorders, and “normal” on INFANIB as-
sessment was defined as negative for neuromotor devel-
opmental disorders. When the results were transient,
infants were followed up with repeat PDMS evaluations
and at-home rehabilitation was recommended without
help from professionals. The sensitivity, specificity, PPV
and NPV were calculated accordingly.
Statistical analysis
The clinical characteristics and INFANIB score are pre-
sented as mean± standard deviations (SD) for continu-
ous variables for preterm and full-term infants and
compared using two-sample t-test. Categorical variables
are presented as n (%) and compared using Pearson Chi-
square test or Fisher’s exact test if the number of cells is
less than five. The inter- and intraobserver differences of
INFANIB measurements were evaluated by their repro-
ducibility. An ICC> 0.90 shows high reliability, 0.75-0.90
reveals good reliability, 0.50-0.75 displays intermediateTable 1 Clinical characteristics of preterm and full-term infan
Variablesa Preterm infants (n = 55)
GA, wk 33.18 ± 2.73 (Range: 27.29 t





Brain damage b 10 (18.2%)
Intracranial hemorrhage 0 (0%)
Maternal hypertension during pregnancy 10 (18.2%)
Hyperbilirubinemia 15 (27.3%)
Neonatal mechanical ventilation over 48 h 4 (7.3%)
a Data are presented as mean ± SD with a range (minimum to maximum) for contin
b Brain damage includes hypoxic ischemic encephalopathy (HIE) of Full-term infant
* p< 0.05 indicates significant difference between preterm and full-term infants.
Abbreviations: GA, gestational age; BW, birth weight; HIE, hypoxic ischemic encephareliability and <0.05 suggests poor reliability. Sensitivity,
specificity, PPV and NPV are shown for the predictive
results of INFANIB assessments according to the PDMS
evaluation. All statistical assessments were two-tailed
and considered significant at p < 0.05. Statistical analyses
were performed using SPSS 15.0 statistics software
(SPSS Inc, Chicago, IL, USA).
Results
Table 1 summarizes clinical characteristics for preterm
and full-term infants. The preterm infants had signifi-
cantly shorter gestational age and lower birth weight. A
significantly higher proportion of full-term infants had
asphyxia, brain damage and hyperbilirubinemia (Table 1).
Ultrasound scans performed 24–72 h after birth for pre-
term infants showed local or extensive echo enhance-
ment in tissues surrounding the cerebral ventricle while
ultrasound scans for full-term infants showed spotty
local or diffuse echo enhancement in tissues surround-
ing the cerebral ventricle accompanied by changes in
cerebral ventricular shape and fuzzy structure and intra-
cranial hemorrhage. The INFANIB and PDMS scores of
all subjects were measured with questionnaires at 3, 7
and 10 months after birth. The ICC-inter values of inter-
observer differences for each age group all showed excel-
lent assessments. INFANIB scores of two raters on two
occasions (test-retest) were used to assess intraobserver
reliability. The ICC-intra of the intraobserver differences
of rater B shows that the assessments were excellent at
3 months and 7 months and were substantial at
10 months (0.68). The ICC-intra values for intraobserver
differences of rater C were excellent for all three age
groups. At 3, 7, and 10 months, no significant differ-
ences were observed in INFANIB scores or diagnostic
results between preterm and full-term infants (Table 2).
According to the PDMS evaluation and diagnosis criteriats (N =104)
Full-term infants (n = 49) p-value
o 36.86) 39.02 ± 1.13 (Range: 37.43 to 41.71) <0.001*









uous variables and n (%) for categorical variables.
s and PVL of Preterm infants.
lopathy; PVL, periventricular leukomalacia.
Table 2 Summary of INFANIB scores and diagnostic









INFANIB score 59.60 ± 9.44 58.78 ± 8.72 0.514
Diagnostic results 0.431
Normal 27 (49.1%) 18 (36.7%)
Transient 15 (27.3%) 16 (32.7%)
Abnormal 13 (23.6%) 15 (30.6%)
7 months
INFANIB score 64.82 ± 9.72 66.47 ± 9.92 0.313
Diagnostic results 0.591
Normal 26 (47.3%) 28 (57.1%)
Transient 13 (23.6%) 9 (18.4%)
Abnormal 16 (29.1%) 12 (24.5%)
10 months
INFANIB score 78.56 ± 8.36 78.14 ± 9.64 0.687
Diagnostic results 0.813
Normal 36 (65.5%) 29 (59.2%)
Transient 8 (14.5%) 8 (16.3%)
Abnormal 11 (20.0%) 12 (24.5%)
a Data are shown as mean ± SD for INFANIB score with Mann–Whitney U test
and n (%) for the diagnostic results with Pearson chi-square test.
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having CP or movement retardation and 42 preterm
infants were normal. Among the full-term infants, 13
infants were diagnosed as having CP or movement re-
tardation and 36 were normal. Although abnormal
PDMS results may indicate movement retardation or CP,
not all children whose results indicate movement retard-
ation also meet the criteria for CP. Table 3 shows the
sensitivity, specificity, PPV and NPV of the INFANIB
based on comparison with the observed results obtainedTable 3 Summary of the predictive results of INFANIB for pre
Observed outcomes fro
Months Diagnostic from INFANIB Abnormala (n = 13) No
3
Abnormalb (n = 28) 10 18
Normal (n = 27) 3 24
7
Abnormalb (n = 29) 11 18
Normal (n = 26) 2 24
10
Abnormalb (n = 19) 11 8
Normal (n = 36) 2 34
a Abnormal in PDMS includes cerebral palsy and movement retardation (GMQ ≤79)
b Abnormal category includes abnormal or transient motor development delay on I
Abbreviations: PDMS, Peabody Developmental Motor Scales; PPV, positive predictivusing the PDMS for preterm infants. INFANIB had rela-
tively high values in sensitivity, specificity, PPV and NPV
at age of 10 months. However, the predictive results of
preterm infants’ status from INFANIB at 3 months and
7 months were much lower values (Table 3).
Table 4 shows the sensitivity, specificity, PPV and NPV
of the INFANIB based on comparison with the observed
results obtained by using the PDMS for full-term infants.
The predictive values of full-term infants’ status from
INFANIB were relatively high at ages of 7 and 10 months
but, again, were much lower for specificity and PPV at
3 months (Table 4).
Discussions
In this study, assessment of a Chinese version of the
INFANIB demonstrated that it had acceptable validity
and reliability and was feasible for screening neuromotor
developmental disorders in Chinese primary care set-
tings. In China, the scales used most frequently in chil-
dren's hospitals that offer comprehensive medicine and
services, e.g. BSID-II, Gesell Developmental Schedules,
PDMS-2, and AIMS [7-10], are time-consuming to ad-
minister and professional staff require specialized train-
ing at professional agencies. Therefore, these scales are
impractical for wide application in Chinese primary care
settings because of the heavy patient load, shortage of
physicians, limited medical resources and low medical
literacy in many community medical facilities. The most
frequently applied scale for assessment of developmental
milestones in China is the Denver Developmental
Screening Test (DDST) [21]. However, the low sensitiv-
ity of this scale makes it unsuitable for identifying motor
development retardation in the first year of life [21],
which is likely due to the relatively small number of de-
velopmental milestones in the infancy stage. The INFA-
NIB is a scale with favorable reliability and validity for
the assessment of neuromotor development [14,22].term infants (N=55)
m PDMS
rmal (n = 42) Sensitivity Specificity PPV NPV
76.9% 57.1% 35.7% 88.9%
84.6% 57.1% 37.9% 92.3%
84.6% 81.0% 57.9% 94.4%
.
NFANIB.
e value; NPV, negative predictive value.
Table 4 Summary of the predictive results of INFANIB for full-term infants (N=49)
Diagnostic results from PDMS
Months Diagnostic from INFANIB Abnormala (n = 13) Normal (n = 36) Sensitivity Specificity PPV NPV
3
Abnormalb (n = 31) 10 21 76.9% 41.7% 32.3% 83.3%
Normal (n = 18) 3 15
7
Abnormalb (n = 21) 11 10 84.6% 72.2% 52.4% 92.9%
Normal (n = 28) 2 26
10
Abnormalb (n = 20) 12 8 92.3% 77.8% 60% 96.6%
Normal (n = 29) 1 28
a Abnormal in PDMS includes cerebral palsy or movement retardation (GMQ ≤79).
b Abnormal category includes abnormal or transient motor development delay on INFANIB.
Abbreviations: PDMS, Peabody Developmental Motor Scales; PPV, positive predictive value; NPV, negative predictive value.
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INFANIB in Chinese primary care settings showed that
all intergroup ICC-inter values were higher than 0.8,
demonstrating high reliability. The ICC-intra values of
intraobserver (test-retest) reliability were also higher
than 0.8 for rater C and for rater B at 3 months and
7 months. These results suggest that the INFANIB is a
reliable and stable scale, and that medical staff with dif-
ferent medical backgrounds can master the application
of this scale as long as the raters have knowledge of neu-
romotor development. In addition, administration of the
INFANIB in this study was time-saving (mean time: 8
minutes), which is consistent with previous reports
[14,22]. Given these findings, we believe that the INFA-
NIB can be widely applied in Chinese primary care set-
tings for screening motor development disorders in
high-risk infants.
To measure validity, we used the PDMS-2 as the gold
standard [8]. Studies have shown this scale to be a valid
evaluative measure of infants receiving physical therapy,
and infants with cerebral palsy and motors delays
[18,23]. The PDMS-2 is widely accepted for the assess-
ment of simple motor development; abnormal results in
the PDMS may indicate movement retardation and cere-
bral palsy but it must be noted that all children identi-
fied to have movement retardation do not meet the
defined criteria for cerebral palsy. In this study, the
INFANIB had good sensitivity and negative predictive
value for both preterm infants and full-term infants
compared with a previous report [14]. However, for full-
term infants at age 3 months, the specificity and positive
predictive value were relatively low, suggesting that there
were a relatively high number of false positives. The
lower validity for 3-month-old infants can possibly be
explained by results of the INFANIB development study
in 1985 [15]. Children in that study were aged from 0 to
22 months and validity was observed to increase withage. The scale is therefore specifically recommended for
use in evaluating infants aged 4–18 months of age [15].
In assessments using the INFANIB, infants are assessed
in the supine, prone, sitting, standing and suspended
positions for body tone, posture, French angles and
primitive reflexes to screen them for abnormal motor
development. These items involve the tension of trunk
extensors, lower limb extensors and adductors, which
may not be easy to measure at the early stage of infancy.
In addition, since the early stage of infants might have
better brain development plasticity, INFANIB results as-
sessment may become unclear after the infants receive
rehabilitation. The most likely explanation, however, is
that poor predictive power is related to poor prediction
of the single items themselves at this early age.
In preterm infants at age 3 and 7 months (corrected
age), the specificity and positive predictive value were
relatively low compared with that previously reported
[14]. Pedersen et al. (2000) also reported that the validity
of the INFANIB for predicting the future presence of CP
was low in premature infants weighing < 2000 g (birth
weight) and aged 7 months (corrected age) since only 8
of 65 infants who were dystonic at 7 months developed
suspected CP [23]. Evidence shows transient dystonia to
different extent in premature infants aged 4–8 months.
Several studies have confirmed that the gross motor de-
velopment in premature infants (including healthy pre-
mature infants) is significantly different from that in
full-term infants, and is characterized by abnormal pos-
ture, abnormal muscular tone and asymmetric position,
at 4–8 months corrected age, which resolves at the age
of 8–12 months [24-28]. This may explain why the valid-
ity of INFANIB for predicting the presence of CP at the
age of 7 months was low in premature infants. It should
be noted that three preterm infants in this study were
diagnosed as having asphyxia based primarily on Apgar
scores (0–3 within 5 minutes of birth is defined as
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umbilical artery blood (<7.0) and the presence of neuro-
logical symptoms (e.g., convulsions, coma, hypotonia)
and symptoms of cardiovascular, gastrointestinal, blood,
respiratory and/or urinary system indications as criteria
for neonatal asphyxia.
Conclusions
In conclusion, assessment using the INFANIB is simple
and time-saving, and the scale has favorable reliability
and acceptable validity at the age of 10 months for both
premature and full-term infants at high-risk for develop-
mental disorders. The INFANIB is therefore an appro-
priate tool for screening neuromotor developmental
disorders in Chinese primary care settings. For prema-
ture infants at the age of 7 months or less, and for full-
term infants at the age of 3 months or less, detecting
abnormalities using the INFANIB does not lead to
the conclusion of motor development delay, even in
high-risk infants.
Limitations
Although our results are useful for follow-up of preterm
and term neonates at risk of neurologial problems in a
Chinese population, the relatively small number of
infants studied and the lack of a control group limits the
strength of study conclusions. We chose not to use a
control group in this study because, while training the
three raters and gaining early experience with INFANIB
in full-term infants and infants with low risk in our
Health Care Clinic, our results showed that scores were
in the normal cut-off point as referenced in the previ-
ously published U.S. study by Ellison, the developer of
the scale [15]. Since the present study aimed to investi-
gate a Chinese version of INFANIB that would be used
with Chinese children, of course controls would have
been useful. Additional multicenter study will be con-
ducted with a large sample and longer neurological out-
come to establish cut-off criteria for evaluation with
INFANIB in Chinese populations. Also, technical, lin-
guistic, and conceptual problems involved in the transla-
tion of questionnaires [30,31], limited the ability to
compare results of studies using the same instruments
in a different language. We also must note that the
poor predictive power seen in infants aged 3 months
may be related to the poor prediction of the single items
at this age, suggesting that only one neurological exam-
ination is an insufficient basis for prognosis, especially at
early ages.
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